Following many successful BSE report applications prepared by VCRO to TFDA,VCRO has once again granted a bridging study waiver approval for a multinational pharmaceutical company on Aug-31-2015. This accomplishment was a continuing achievement for VCRO’s BS waiver records following 2 biological products in 2014. Client saves considerable budget and time to bring this product to market in Taiwan.
Congratulations! More Bridging Study Evaluation (BSE) Waivers granted by TFDA
Following many successful BSE report applications prepared by VCRO to TFDA,VCRO has once again granted a bridging study waiver approval for a multinational pharmaceutical company on Aug-31-2015. This accomplishment was a continuing achievement for VCRO’s BS waiver records following 2 biological products in 2014. Client saves considerable budget and time to bring this product to market in Taiwan.